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A B S T R A C T
Pharmaceutical tests for hard shell capsules are designed for orally administered capsules. The use of
capsules in dry powder inhalers is widespread and increasing and therefore more appropriate tests are
required to ensure quality and determine if these capsules are ﬁt for purpose. This study aims to
determine the ﬂexibility, reproducibility and sensitivity of a quantitative method that is designed to
evaluate the puncture characteristics of different capsule shell formulations under different climatic
conditions. A puncture testing method was used to generate force displacement curves for ﬁve capsule
formulations that were stored and tested at two different temperatures (5 C and 19 C). Force-
displacement puncture proﬁles were reproducible for individual capsule shell formulations. The
methodology was able to discriminate between capsules produced using different primary materials i.e.
gelatin versus hypromellose, as well as more minor changes to capsule formulation i.e. different material
grades and excipients. Reduced temperature increased the forces required for capsule puncture however
further work is required to conﬁrm its signiﬁcance. Results indicate the method provides a reproducible
and sensitive means of evaluating capsule puncture. Future studies should validate the methodology at
different test sites, using different operators and with different capsule shell formulations.
ã 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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Dry powder inhalers (DPIs) are used to deliver micronized
drugs to the lungs, typically to treat pulmonary disease (Atkins
2005; Pavkov et al., 2010). In some DPIs hard shell capsules are
used as a single-dose container for the drug in association with a
carrier excipient. To facilitate pulmonary drug delivery from such
devices the capsule wall is either punctured with a set of
sharpened pins or cut by a blade. The powdered drug is then
released from the capsule and entrained into the airﬂow upon
inspiration by the user (Jones 2003). DPIs are established delivery
systems that have formed the basis of many highly successful drug
products for the treatment of asthma and COPD. In recent years
there has also been an increase in new capsule products for use in
DPIs.
A hard shell capsule consists of two open-ended cylinders, a cap
and body, that ﬁt one inside the other (Jones, 2004). The capsule* Corresponding author at: Redwood Building, King Edward VII Avenue, Cardiff
CF10 3NB, United Kingdom.
E-mail address: coulmansa@cardiff.ac.uk (S.A. Coulman).
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0378-5173/ã 2016 The Authors. Published by Elsevier B.V. This is an open access articmanufacturing process typically involves sourcing raw materials,
preparing a solution of the capsule shell formulation, dipping
standard rod-shaped-moulds into this solution, drying the ﬁlms
formed, removing them from the moulds and cutting the dried
capsule shells to the correct length before joining the capsule body
and cap together. Pharmaceutical materials used to manufacture
DPI capsules are typically based on either gelatin or hydroxypropyl
methylcellulose (HPMC). Gelatin, which is commonly derived from
collagen that has been extracted from bovine bone and skin, has
been used by the pharmaceutical industry to manufacture hard
shell capsules for more than a century. The properties of this
biological material are governed, in part, by the source of the raw
material and the processing steps that are used. Under ‘normal’
storage conditions gelatin capsules have a water content of 13.0–
16.0%. This water acts as a plasticiser in gelatin ﬁlms and therefore
in low humidity conditions gelatin capsules become brittle and
prone to breakage on transport or during use (Jones 2003; Nagata
2002). HPMC capsules are used as an alternative to gelatin as they
offer particular advantages: they are made from a plant-derived
material, the capsule shells have a signiﬁcantly lower moisture
content, 4.0–6.0%, maintain appropriate physical properties whenle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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moisture-labile compounds (Nagata 2002; Ogura et al., 1998).
Hard shell capsules were originally developed for oral dosage
forms and the Pharmacopoeial tests are for ﬁlled capsules and not
for empty ones. None are designed to evaluate the mechanical
properties of capsule shells, a key parameter when the aim is to
introduce an inhaler pin into the capsule to create a hole for
powder emission. There is therefore a need to establish more
predictive tests for capsule performance in DPIs that are robust
enough to be used for quality assurance purposes and yet sensitive
enough to detect minor changes in capsule properties. Our group
have recently developed a methodology that can be used to
evaluate the puncture performance of capsules that are to be used
in DPIs (Torrisi et al., 2013), however, further work is required to
determine the reproducibility, sensitivity and ﬂexibility of the
method.
Patients do not always appreciate the importance of correct
storage (Renswoow et al., 2010) or are unable to adhere to storage
instructions. However, DPIs are used in countries and regions, with
very different climatic conditions, and therefore ﬁlled capsules, for
use in DPIs, are often packaged in blisters. Blister packing ensures
that under adverse storage conditions capsules are offered some
protection from moisture gain or loss. DPIs are used by patients in
many different climatic conditions, for example in northern climes
during winter they will be used at lower temperatures. The
potential use of biologics in DPIs may also necessitate storage in
the refrigerator. However, little is known about the inﬂuence of
temperature on the performance of capsules in DPIs. This study
uses a previously reported method (Torrisi et al., 2013) to
characterise the puncture of ﬁve different capsule formulations,
using a pin from a DPI, at two different time points and at two
different temperatures (5 C and 19 C). The aim is therefore to
establish the reproducibility, sensitivity and ﬂexibility of the
method as a means to control the quality of empty capsule
formulations, intended for use in DPIs, and potentially predict their
performance under different climatic conditions. A secondary
objective is to extend the previously described method to provide
semi-quantitative characterisation of capsule punctures.
2. Materials and methods
2.1. Capsule conditioning at controlled temperature and humidity
Five different capsule shell formulations (labelled A–E; Table 1),
provided by Qualicaps Europe, S.A.U. (Alcobendas, Spain), were
conditioned either in a cold room (target temperature 5 C) or in a
temperature controlled room (target temperature 19 C) for a
minimum period of 7 days. All capsules were stored in desiccators
over either a saturated solution of calcium chloride (Sigma–
Aldrich, Poole, UK), to create a capsule moisture content in the
lower part of the normal moisture speciﬁcation limits (13–16% for
gelatin and 4.5–6.5% for HPMC inhalation grade capsules), or
magnesium nitrate (Sigma–Aldrich, Poole, UK), to create an
environment that resulted in capsule formulations with moisture
contents in the upper part of the normal range or slightly above.
Capsules A–D consisted of a blend of HPMC, carrageenanTable 1
The denominations and descriptions of the capsule shell formulations tested in this st
Capsule label Description 
A Quali-V1-I transparent clear 
B Quali-V1-I opaque white 
C Quali-V1 grade A transparent orange 
D Quali-V1 grade B transparent clear 
E Hard transparent clear (a gelation aid) and potassium chloride (a network promoter).
Capsule D was produced from HPMC that had been sourced from a
different supplier than capsules A–C. Capsules A and D were
colorless, capsule B contained titanium dioxide (and was therefore
white) and capsule D contained FD&C yellow. The loss of water on
drying (LOD) test (Council of Europe, 2005), was used to determine
the moisture content of capsules both prior to and during the
testing period.
2.2. Capsule puncture force measurements
The force of capsule puncture was measured and recorded using
a Zwick materials testing machine (Herefordshire, UK), as
previously described (Torrisi et al., 2013). However, to enable
testing to take place in different locations (a temperature
controlled room and a cold room) the materials testing machine
and accompanying hardware were mounted on a mobile heavy-
duty trolley, which was re-positioned as necessary. Puncture tests
were performed at a test speed of 10 mm/minute with an angular
single metal pin from a RS01 2-pin inhaler (Plastiape S.p.A; Milan,
Italy). This was attached via a chuck to the materials testing
machine, which converts the force of puncture into a measurable
electrical voltage. Tests were conducted multiple times (N = 10) at
two different time points for each capsule type in order to evaluate
test reproducibility.
2.3. Physical characterisation of punctured capsules
All punctured capsules from a single experimental set (N = 10)
were mounted in a cap bushing from a capsule ﬁlling machine
(Qualicaps Europe S.A.U) and inspected visually using an AmScope
Stereo Inspection Microscope (CA, USA). Representative images
were captured using the MU900 integrated digital camera (3.3–
180 zoom) within 30 min of capsule puncture. The shape of the
capsule puncture was recorded as regular or irregular (Fig. 1), the
presence or absence of a ﬂap at the point of puncture was recorded
and the cross sectional area of the puncture (Fig. 2) was measured,
relative to the capsule cross sectional area, using ImageJ (NIH, USA)
software.
2.4. Data processing and statistical analysis
Figures were generated and statistical analyses (unpaired two-
tailed t-tests) were performed using Prism 5 for Mac OS X
(GraphPad Software Inc., USA).
3. Results
3.1. Capsule conditioning
The mean average daily temperature in the temperature
controlled room was 19  0.19 C and in the cold room was
4.8  0.23 C. The humidity in the temperature controlled room
and cold room was 44.9  4.0% and 81.8  5.2% respectively,
however, capsules were stored in desiccators in order to control
their moisture content. Table 2 provides detail of the moistureudy.






Fig. 1. Representative images of regular and irregular capsule puncture shapes in some of the capsules tested in this study.
Fig. 2. A representative image to illustrate the area of capsule puncture that was
recorded and quantiﬁed using ImageJ software.
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before and during the puncture testing period. Generally, when
stored at 19 C over either CaCl2 or Mg(NO3)2 the capsules moisture
contents were at the lower and upper half of the normal moisture
speciﬁcation limits (4.5–6.5% for HPMC and 13.0–16.0% gelatin),
respectively. At 5 C the moisture content in desiccators was more
difﬁcult to control due to the higher atmospheric humidity. At 5 C
those conditioned over CaCl2 were within the upper half of theTable 2
The mean ( standard deviation) moisture content of capsule formulations A–E when sto
tests conducted on different days.
Condition Capsule type
A B 
19 C CaCl2 4.38  0.39% 4.50  0.21% 
Mg(NO3)2 6.64  0.23% 6.17  0.42% 
5 C CaCl2 6.07  0.43% 5.90  0.33% 
Mg(NO3)2 7.16  0.54% 6.95  0.30% moisture speciﬁcation and those conditioned over Mg(NO3)2 were
slightly above the normal moisture speciﬁcation.
3.2. Impact of formulation and climatic conditions on capsule
puncture by a DPI pin
3.2.1. Evaluating the reproducibility of capsule puncture
The typical puncture force proﬁle of a capsule has been
characterised previously (Torrisi et al., 2013). The shape of the
puncture proﬁle (Fig. 3) and the maximum force recorded (i.e. the
force required to puncture the capsule) (Table 3) is signiﬁcantly
different between capsule materials i.e. HPMC (Fig. 3A–D) versus
gelatin (Fig. 3E). A double peak is clearly evident in Fig. 3E and is a
signature of gelatin puncture, whereas this double peak is typically
absent in HPMC puncture proﬁles (Fig. 3A–D). More minor changes
to the HPMC capsule formulation also change the magnitude of the
puncture force (Table 3), although the overall shape of the
puncture proﬁle appears less affected.
The reproducibility (intra-experimental variability) of the
method is demonstrated by comparing individual proﬁles within
a single set of data (Fig. 3A Set 1) and the repeatability of the test
(inter-experimental variability) can be evaluated by comparing
experiments conducted 8 days apart (Fig. 3A Set 1 versus Set 2).
The intra- and inter-experimental reproducibility of the method-
ology, at both the studied temperatures, is exempliﬁed by the
puncture forces and associated standard deviations for capsule
formulation A (Table 3). Other capsules, most notably capsule C,
have more variable puncture forces within an experiment,red at either 5 C or 19 C and over either CaCl2 or Mg(NO3)2. Results are from 2 LOD
C D E
4.85  0.11% 4.60  0.24% 13.22  0.37%
6.51  0.38% 6.23  0.42% 14.58  0.32%
6.17  0.28% 5.82  0.18% 14.60  0.10%
7.17  0.53% 7.06  0.16% 14.80  0.01%
Fig. 3. The puncture proﬁles of 5 different capsule formulations (labelled A–E) stored and tested at 19 C in CaCl2. Data is presented in duplicate sets (set 2 is an experimental
replicate of set 1, conducted 8 days later) to evaluate reproducibility. Forcemax = force required for needle to penetrate capsule shell; dL at forcemax = distance of needle
displacement prior to penetration. N = 10 for each capsule type in each condition.
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Table 3
The mean ( standard deviation) maximum force (Fmax) recorded upon penetration of capsule formulations A–E when stored at either 5 C or 19 C and over either CaCl2 or
Mg(NO3)2. Results of two experimental sets (each N = 10) are presented to demonstrate reproducibility of the methodology.
Condition Experiment Capsule formulation
A B C D E
19 C CaCl2 1 3.25  0.57 N 2.34  0.30 N 4.79  1.10 N 3.03  0.34 N 5.57  0.72 N
2 3.24  0.43 N 2.69  0.35 N 4.90  0.75 N 3.40  0.52 N 5.67  0.70 N
Mg(NO3)2 1 2.56  0.34 N 2.21  0.24 N 3.93  1.09 N 2.81  0.45 N 5.28  0.93 N
2 2.67  0.28 N 2.40  0.30 N 3.67  0.58 N 2.99  0.62 N 5.43  0.75 N
5 C CaCl2 1 3.24  0.80 N 2.56  0.34 N 4.61  0.59 N 3.62  0.84 N 6.31  0.96 N
2 3.43  0.51 N 2.67  0.43 N 5.24  2.50 N 3.71  0.91 N 5.47  0.60 N
Mg(NO3)2 1 2.96  0.37 N 2.51  0.45 N 3.86  0.57 N 2.66  0.32 N 6.13  0.80 N
2 2.78  0.46 N 2.23  0.14 N 4.31  0.79 N 2.85  0.47 N 5.84  0.89 N
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and greater standard deviation values (Table 3).Fig. 4. The impact of capsule shell formulation on the force needed to puncture capsules
capsule shell formulations (A–E) that are stored over CaCl2 or Mg(NO3)2. Error bars repres
different capsule formulations (A–E) with the DPI pin, conditioned either over CaCl2 (ii) o
Tukey’s multiple comparison test. NS denotes a p > 0.05; *** denotes p < 0.001, ** deno3.2.2. The inﬂuence of formulation on the force required to puncture
capsules with a DPI pin
Fig. 4 combines data from the ﬁrst and second set of
experiments to summarise the differences in the puncture force
required for the capsule shell formulations A to E when with a DPI pin at 19 C. (i) A comparison of the mean puncture force recorded for ﬁve
ent standard deviation; N = 20. Statistical differences in the puncture force of the ﬁve
r Mg(NO3)2 (iii) were determined using one-way analysis of variance (ANOVA) and
tes p < 0.01 and * denotes p < 0.05 (N = 20).
Table 4
A summary of the percentage of capsules that displayed a ‘regular’ shaped puncture
following removal of the angular DPI pin from punctured capsules (n = 10).
Condition Capsule type
A B C D E
19C CaCl2 100% 100% 100% 100% 40%
Mg(NO3)2 100% 100% 100% 100% 80%
5C CaCl2 100% 100% 100% 100% 50%
Mg(No3)2 100% 100% 100% 100% 60%
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forces required for the gelatin capsule (capsule E) are signiﬁcantly
different from all HPMC formulations (capsule A–D) at both
humidities (p < 0.001 in all cases except with capsule C stored over
CaCl2) (Fig. 4). There are also signiﬁcant differences (p < 0.001)
between the puncture force for capsule C and all other HPMC
capsule formulations (Capsules A, B and D) at both humidities. The
differences in puncture force between capsules A, B and D were
less signiﬁcant and in some cases there was no statistical
difference, most notably in the case of capsules A and D, which
were not signiﬁcantly different at either of the tested humidities
(Fig. 4).
3.2.3. The inﬂuence of storage temperature on the force required to
puncture capsules with a DPI pin
Capsule shell formulations conditioned over CaCl2 i.e. the lower
moisture speciﬁcation tested, required greater forces to facilitate
puncture compared to those conditioned over Mg(NO3)2 (Fig. 5i).
This difference is statistically signiﬁcant in HPMC capsule
formulations A, B and C at 19 C, and capsule formulations A, B
and D stored at 5 C (p  0.05). The differences between capsule
puncture forces at the two studied temperatures (5 C and 19 C)
were less predictable (Fig. 5ii). There was a trend towards higher
puncture forces being required at the lower temperature. This
difference was not statistically signiﬁcant except in the cases of the
puncture forces required for capsule D when conditioned over
CaCl2 and capsule formulations A and E when stored over Mg
(NO3)2 (p < 0.05). Generally, temperature (Fig. 5ii) generally hadFig. 5. The impact of storage conditions on the force needed to puncture capsules w
formulations (A–E) that are either over (i) CaCl2 or Mg(NO3)2 and (ii) at 19 C and 5 C. An 
the compared groups, which are denoted by * (p < 0.05) or *** (p < 0.001); error bars rless impact on the puncture force than the moisture content
(Fig. 5i).
3.2.4. The inﬂuence of formulation and storage conditions on the
puncture area created in a capsule by a DPI pin
The shape (Table 4) and area (Fig. 6) of capsule punctures
provided qualitative data related to the puncturing event. At both
19 C and 5 C the shape of the punctured created in the HPMC
capsule formulations (A–D) was considered to be “regular” (Fig. 1)
on all occasions, whilst between 20% and 60% of the gelatin
capsules had irregular puncture shapes, depending on the capsule
storage conditions (Table 4). A greater percentage of gelatin
capsules with lower moisture contents (stored over CaCl2) had
irregular shaped punctures compared to those capsules with
higher moisture contents (stored over Mg(NO3)2). Following
puncturing a ﬂap was visible in all HPMC and gelatin capsules.ith a DPI pin. A comparison of the mean puncture force recorded for ﬁve capsule
independent sample two-tailed t-test was used to calculate signiﬁcant differences in
epresent standard deviation; N = 20.
Fig. 6. The impact of capsule shell formulation on the puncture area created by a DPI pin at 19 C. (i) A comparison of the mean puncture area recorded for ﬁve capsule shell
formulations (A–E) that are stored over CaCl2 or Mg(NO3)2. Error bars represent standard deviation; N = 10. Statistical differences in the puncture area of the ﬁve different
capsule formulations (A–E), conditioned either over CaCl2 (ii) or Mg(NO3)2 (iii) were determined using one-way analysis of variance (ANOVA) and Tukey’s multiple
comparison test. NS denotes p > 0.05; *** denotes p < 0.001, ** denotes p < 0.01 and * denotes a p < 0.05 (N = 10).
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capsules stored over Mg(NO3)2 ranged from 0.79  0.08 mm2 for
Capsule A to 0.89  0.09 mm2 for Capsule B. This difference was
statistically different (p < 0.05), although it should be noted that
the puncture areas for other HPMC capsules stored over Mg(NO3)2
were not statistically different (Fig. 6ii). At this humidity, differ-
ences between the puncture area of all HPMC capsule formulations
and the gelatin formulation were clearly evident, with all four
HPMC capsules possessing notably smaller puncture areas than
their gelatin counterpart. At the lower humidity (capsules stored
over CaCl2) the puncture areas were generally smaller than the
higher humidity (Figs. 6i and 7 ii ), although this was not always
statistically signiﬁcant. Differences between the gelatin and the
HPMC formulations were less obvious. At the lower moisture
content results were more comparable to the puncture force data
(Fig. 4ii), whereby formulations A and D performed comparably
and were signiﬁcantly different to gelatin capsules (capsule E).
In general, capsules stored and tested in a temperature
controlled room (19 C) produced signiﬁcantly larger capsule
puncture areas compared to those capsules stored and tested at the
lower temperature of 5 C (Fig. 7i). This difference was statistically
signiﬁcant (p < 0.01) in all of the tested formulations except gelatin
capsules (capsule E) stored over CaCl2. Capsules with higher
moisture content (stored over Mg(NO3)2) appeared to produce
slightly larger puncture areas compared to those capsules with
lower moisture content (stored over CaCl2), although these
differences were not always statistically signiﬁcant (Fig. 7ii).4. Discussion
The performance of hard shell capsules in a DPI is affected by
numerous factors including the capsule formulation (Coates et al.,
2005), the DPI design (Martinelli et al., 2015; Shur et al., 2012) and
use of the device within the clinical environment (Islam and Cleary,
2012). In this study a novel capsule puncture method, previously
described by Torrisi et al. (2013), was extended to evaluate
whether the methodology was sensitive enough to detect minor
changes in capsule formulation, robust enough to provide
reproducible data at two different time points and ﬂexible enough
to evaluate capsule puncture at low temperatures.
The puncture forces recorded for a speciﬁc formulation, stored
in controlled conditions, were reproducible within experiments
(N = 10) and were associated with small standard deviations
(Table 3). The shapes of the puncture proﬁles were also comparable
(Fig. 3). The reproducibility of the puncture test data obtained at
two different time points further exempliﬁes this and indicates
that the method is robust, both at the intra- and inter-
experimental levels, and therefore appropriate as a means to
investigate how capsule formulation and storage parameters can
inﬂuence the properties of hard shell capsules.
Results support previous observations, Torrisi et al. (2013), in
which the method was able to clearly discriminate between
capsules produced using different primary materials i.e. HPMC and
gelatin capsules. However, data presented in this study also
indicates that the method is able to detect more minor changes to
Fig. 7. The impact of storage conditions on the puncture area created by a DPI pin that is inserted into the capsule at a known speed. A comparison of the mean puncture force
recorded for ﬁve capsule formulations (A–E) that are stored at 19 C and 5 C (i) and either over CaCl2 or Mg(NO3)2 (ii). An independent sample two-tailed t-test was used to
calculate signiﬁcant differences in the compared groups, which are denoted by *(p < 0.05), **(p < 0.01) or ***(p < 0.001); error bars represent standard deviation; N = 10.
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other excipients. Changes to the raw HPMC material (Capsule D)
has had little effect on the capsules puncturing properties,
however results for capsule C indicate that small changes to the
formulation of a capsule can have signiﬁcant effects in terms of the
puncture force required and also the variability of this puncture
performance (Fig. 3). This method is therefore highly relevant to
those involved in the formulation and quality control of hard shell
capsules, whereby changes to capsule materials, formulations or
their method of manufacture could impact their performance.
Current pharmacopoeial tests for capsule are for ﬁlled products,
e.g. disintegration and dissolution tests, but these tests were
developed for oral capsules. A speciﬁc puncture force and its
associated puncture proﬁle may provide a standard measure that
can be used to control the quality of capsule shells intended for use
in DPIs. Our method (Torrisi et al. in 2013) therefore has the
potential to provide the sensitivity and reproducibility that would
be required for a standardised assay of capsule puncture.
Previous studies have illustrated the effect of humidity on the
water content of capsules and their resulting performance in DPIs
(Birchall et al., 2008). Signiﬁcant differences in the force required
to puncture capsules stored at ‘normal’ and ‘low’ humidities have
also been identiﬁed previously (Birchall et al., 2008; Torrisi et al.,
2013), with capsules with lower moisture contents requiring a
higher force for puncture compared to capsules with higher
moisture contents. These studies illustrate that uncontrolled
storage conditions, with respect to humidity, can impact on
capsule puncture and potentially performance. Capsules used inthis study were conditioned to be within their moisture
speciﬁcations, at the lower and upper ends of the ‘normal range’.
Although the difference in moisture content was minimal, and
acceptable with respect to clinical use, capsule puncture forces
were higher at the lower moisture content for all formulations
tested at 19 C (Fig. 5i). Not all of these differences were statistically
signiﬁcant but the data is consistent with observations in previous
studies as HPMC and gelatin capsules with lower moisture
contents are less pliable and thus are more resistant to puncture
(Birchall et al., 2008; Torrisi et al., 2013). This indicates that the
puncture testing method is sensitive enough to detect changes in
capsule puncture properties, which may result from storage at
slightly different relative humidities. However, although the data
exempliﬁes the sensitivity of the method and its potential in the
quality control of capsules, it does not predict whether such
changes will have impact on clinical utility.
In general, greater puncture forces were recorded for capsules
stored and tested in the cold (5 C) room compared to the air-
conditioned (19 C) room, however in many cases these differences
were not statistically signiﬁcant (Fig. 5ii). It may therefore be
concluded that reduced temperature has little effect on the forces
required to puncture capsules. However, the capsule moisture
content of each capsule shell formulation was higher at the lower
temperature (Table 2) and this is a confounding factor. The
moisture content of capsules stored at the higher humidity (stored
over (MgNO3)2) increased by a mean average 0.70% for the HPMC
capsule formulations (Capsules A-D) and 0.22% for the gelatin
capsule formulation (Capsule E) when the storage temperature
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(capsules stored over CaCl2) the reduction in temperature resulted
in a mean average 1.41% increase in the moisture content of HPMC
capsule formulations and a 1.38% moisture content increase for the
gelatin capsule formulation (Table 2). Increased capsule moisture
content reduces the force required to puncture capsules (Fig. 5i).
Therefore whilst the data indicates a trend towards lower puncture
forces being required at the lower temperature, this is likely to be
offset by a simultaneous rise in the moisture content of the
capsules. Data for capsules stored over (MgNO3)2, where moisture
content was more comparable, may be considered to be more
representative of the impact of temperature alone on puncture
force but the high sensitivity of the method means that the
inﬂuence of the increased humidity at lower temperatures cannot
be discounted. The inﬂuence of low temperature on both the
capsule moisture content and the puncture properties of capsules
should therefore be considered during the manufacture, packaging
and clinical use of capsules.
The shape and area of the capsule puncture is another indicator
of quality of inhalation grade capsules and also potentially
inﬂuences drug powder release from the capsule. In all conditions
tested HPMC capsules produced regular shaped punctures with
ﬂaps attached, whilst gelatin capsules (capsule E) had a proportion
of irregular shaped punctures. This, and other studies have
indicated that HPMC inhalation grade capsules are more ﬂexible
than gelatin (Kuentz et al., 2006; Podczeck, 2002; Torrisi et al.,
2013) and all HPMC formulations tested in this study produced
more reproducible puncture shapes (Table 4). However, further
work is needed to conﬁrm whether irregular puncture shapes
impact on the clinical performance of the capsule, i.e. dose
emission and pulmonary deposition.
Differences in the puncture areas between capsule formula-
tions were less predictable. However, results indicate that capsule
puncture area is signiﬁcantly affected by temperature, whereby
capsules stored and tested at 5 C had much smaller areas
compared to those tested at 19 C. This difference was signiﬁcant
and consistent for all capsule formulations tested. Whilst this is an
interesting observation, it is difﬁcult to disentangle the impact of
temperature and humidity, as previously discussed. This particular
ﬁnding warrants further investigation as major differences in the
size of the oriﬁce created in a capsule may impact on DPI
performance and the resulting clinical outcome. However, it is
important to stress that the physical characterisation of capsule
puncture area is a semi-quantitative method that is constrained by
the imaging technique i.e. a microscope captures a two-dimen-
sional image of a three-dimensional event. Thus this technique has
some limitations for routine quality control use, but does provide a
good qualitative indication of how storage conditions affect
capsule puncture area. Future studies should investigate the
potential of imaging systems that can provide three dimensional
images i.e. data in the x, y and z plane, in order to better
characterise the oriﬁce, and the associated ‘ﬂap’, that is created in a
capsule during puncture by a DPI. This would provide an estimate
of the volume of the aperture through which powdered drug must
ﬂow in order to be aerosolised and inspired by a patient.
Current quality assurance testing for capsules uses tests that are
developed for orally administered dosage forms. Therefore, it is
important that a robust method for testing capsules that are used
in DPI products is developed for routine quality assurance during
capsule shell manufacture. The consistency, reproducibility and
ﬂexibility of the puncture force testing methodology described in
this study has signiﬁcance for those developing and manufacturing
hard shell capsules. Capsule manufacturers could adopt this rapid
and robust testing methodology to evaluate how manufacturing
variations, such as different raw materials, different manufacturing
sites and changes in storage, will affect the puncture quality of thecapsules produced. This study has also illustrated the ﬂexibility of
the method, conducting tests at two different temperatures.
However this could be taken further, as the method could be easily
adapted to use different DPI pins and different insertion speeds to
more closely mimic a speciﬁc DPI. In addition to puncture
performance the methodology has the potential to provide a
predictor of DPI performance, however further work is needed to
correlate capsule puncture with powder aerosolization and
subsequent deposition.
5. Conclusion
This study demonstrates the ﬂexibility, reproducibility and
sensitivity of a methodology that can be used to determine
differences in the puncture performance of different capsule shell
formulations stored at different humidities and at different
temperatures. This simple and rapid laboratory test provides a
valuable tool for the quality assurance of commercial capsule shell
formulations, intended for use in DPIs, made from different
materials or using different manufacturing methods. Further work
is now required to provide three-dimensional characterisation of
the oriﬁce created in a capsule by a DPI and to determine how
features of capsule puncture correlate with subsequent DPI
performance.
Whilst further work is needed to ascertain the impact of
temperature alone on puncture performance, results suggest that
capsule storage in a low temperature (5 C) environment
necessitates slightly greater forces to facilitate capsule puncture
and results in oriﬁces that are smaller than those created at room
temperature. This may have implications for DPIs used in colder
climes. Further work needs to be conducted to better understand
the relationship between temperature, humidity and the force
required for capsule puncture.
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